Oxford Nanopore Raises $59M to Support MinIon Commercialization, R&D for New Products | GenomeWeb

NEW YORK (GenomeWeb News) — Oxford Nanopore Technologies has raised £35 million ($59 million) from existing and new investors, bringing its total funding since its founding in 2005 to £180 million ($302 million).

The new funding, through a private placement of ordinary shares, comes from investors in the UK, the US, and mainland Europe. The CF Woodford Equity Income Fund, which is managed by Woodford Investment Management, is one of the new investors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.